India's Cipla to Build Biosimilar Plant in South Africa

Source: Business Standard

Jul 11, 2016

Mumbai-based Cipla announced plans to build a $89 million biosimilar manufacturing plant in the coastal city of Durban.

The Cipla BioTec plant -- the first South African facility for Cipla's biotechnology arm -- will manufacture biosimilars at lower costs for South Africa. There is also potential to export to the U.S., Europe and Asia, said the company.

Construction for the new facility is scheduled to start in early 2017, with full operations expected to commence in the third quarter of 2018.

Read the Business Standard coverage

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments